Видео ютуба по тегу Biocon Fund Raise Plans

Biocon Board Meet On Dec 6; Investment In Biocon Biologics, Fundraising Plans Key Focus Areas
Biocon Board Meet On Dec 6; Investment In Biocon Biologics, Fundraising Plans Key Focus Areas
Заседание совета директоров Biocon, посвященное сбору средств, в первую очередь, для развития биз...
Заседание совета директоров Biocon, посвященное сбору средств, в первую очередь, для развития биз...
Biocon Raises ₹4,500 Cr Via QIP | Fund Utilisation Plans | MD & CEO Siddharth Mittal | ET Now
Biocon Raises ₹4,500 Cr Via QIP | Fund Utilisation Plans | MD & CEO Siddharth Mittal | ET Now
Компания Biocon находится под давлением в преддверии заседания совета директоров 6 декабря | CNBC...
Компания Biocon находится под давлением в преддверии заседания совета директоров 6 декабря | CNBC...
Biocon CEO On Raising Rs 4,500 Through QIP & Expansion Plans
Biocon CEO On Raising Rs 4,500 Through QIP & Expansion Plans
Biocon To Merge Biocon Biologics; To Issue Shares At ₹405.60 To Biocon Biologics Shareholders
Biocon To Merge Biocon Biologics; To Issue Shares At ₹405.60 To Biocon Biologics Shareholders
Biocon–Biocon Biologics Merger $5 5 Billion Valuation & ₹4,500 Cr Fund Raise #Biocon#BioconBiologics
Biocon–Biocon Biologics Merger $5 5 Billion Valuation & ₹4,500 Cr Fund Raise #Biocon#BioconBiologics
There Was A Strong Demand For The QIP From Both Domestic & Foreign Investors: Biocon | CNBC TV18
There Was A Strong Demand For The QIP From Both Domestic & Foreign Investors: Biocon | CNBC TV18
Reporter's Take | Biocon Biologics raises Rs 530 crore at steep $3 bn valuation
Reporter's Take | Biocon Biologics raises Rs 530 crore at steep $3 bn valuation
Biocon ka Game Plan badal gaya? | Markets by Zerodha Hindi
Biocon ka Game Plan badal gaya? | Markets by Zerodha Hindi
Biocon Sells Another 10% Stake In Syngene: Siddharth Mittal Speaks On The Firm's Fund Raise Pipeline
Biocon Sells Another 10% Stake In Syngene: Siddharth Mittal Speaks On The Firm's Fund Raise Pipeline
Where to Invest Now? 4 Triggers to Watch (SBI, Biocon, EV Sector, Rupee)
Where to Invest Now? 4 Triggers to Watch (SBI, Biocon, EV Sector, Rupee)
Global Biosimilars Week
Global Biosimilars Week
Biocon Biologics's Shreehas Tambe Speaks On US FDA's Observation | Bazaar Open Exchange | CNBC-TV18
Biocon Biologics's Shreehas Tambe Speaks On US FDA's Observation | Bazaar Open Exchange | CNBC-TV18
Biocon Biologics To Close Viatris Deal Soon, IPO Plan Likely In 12-24 Months
Biocon Biologics To Close Viatris Deal Soon, IPO Plan Likely In 12-24 Months
Biocon Biologics Integration into Biocon Limited
Biocon Biologics Integration into Biocon Limited
Biocon Eyes Equity Investments for Debt Reduction Says Kiran Mazumdar-Shaw | Exclusive | CNBC TV18
Biocon Eyes Equity Investments for Debt Reduction Says Kiran Mazumdar-Shaw | Exclusive | CNBC TV18
Stock Market Live | Infosys, Biocon, Anand Rathi, NBCC, Transrail Lighting Share में क्या करें?
Stock Market Live | Infosys, Biocon, Anand Rathi, NBCC, Transrail Lighting Share में क्या करें?
Bank Nifty Breaks Streak | Biocon Fundraise | BPCL & Adani Green JV | Nifty Resistance at 24,550?
Bank Nifty Breaks Streak | Biocon Fundraise | BPCL & Adani Green JV | Nifty Resistance at 24,550?
Biocon Biologics Q3: Biosimilars Revenue Up 54%, EBITDA Up 53% YoY
Biocon Biologics Q3: Biosimilars Revenue Up 54%, EBITDA Up 53% YoY
Biocon Acquires Viatris' Biosimilars Biz: Kiran Mazumdar-Shaw On Deal Rationale & Growth Road Map
Biocon Acquires Viatris' Biosimilars Biz: Kiran Mazumdar-Shaw On Deal Rationale & Growth Road Map